Approvals/CIMA-AEMPS/RIVASTIGMINA AUROVITAS SPAIN 13,3 MG/24 H PARCHES TRANSDERMICOS EFG

Approved

STANDARD

RIVASTIGMINA AUROVITAS SPAIN 13,3 MG/24 H PARCHES TRANSDERMICOS EFG

Aurovitas Spain, S.A.U.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 15e5e1f9bbf65c09
Drug Cima Aemps Name: RIVASTIGMINA AUROVITAS SPAIN 13,3 MG/24 H PARCHES TRANSDERMICOS EFG
Register Number: 88048
Holder Company Name: Aurovitas Spain, S.A.U.
Marketing Company Name: Aurovitas Spain, S.A.U.
Authorization Date: 2022-08-25
Dosage Form: PARCHE TRANSDÉRMICO
Dose: 13,3 mg/24 h
Route Of Administration: VÍA TRANSDÉRMICA
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Aurovitas Spain, S.A.U.

RIVASTIGMINA

19,2 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Aug 25, 2022

Approval ID

15e5e1f9bbf65c09

Type

Standard